Fiduciary Alliance’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16M Buy
1,725
+641
+59% +$381K 0.09% 213
2026
Q2
$544K Sell
1,084
-6
-0.6% -$2.88K 0.04% 357
2026
Q1
$580K Buy
1,090
+538
+97% +$292K 0.04% 347
2025
Q4
$320K Buy
552
+81
+17% +$45.8K 0.02% 411
2025
Q3
$229K Sell
471
-31
-6% -$14.4K 0.02% 464
2025
Q2
$204K Sell
502
-1,046
-68% -$437K 0.02% 458
2025
Q1
$770K Sell
1,548
-10
-0.6% -$5.42K 0.08% 201
2024
Q4
$811K Buy
+1,558
New +$857K 0.08% 183
2023
Q3
– Sell
-100
Closed -$52.2K – 871
2023
Q2
$52.2K Buy
+100
New +$54K 0.01% 312
2023
Q1
– Sell
-24
Closed -$13.2K – 802
2022
Q4
$13.2K Buy
+24
New +$12.7K ﹤0.01% 362

Other funds holding TMO

Fiduciary Alliance's TMO Position: Q3 2026 in Review

Fiduciary Alliance increased its Thermo Fisher Scientific (TMO) stake by 59% in Q3 2026, buying an estimated $381K and bringing the position to 1,725 shares worth $1.16M. The position accounts for 0.09% of the portfolio, ranked #213.

Fiduciary Alliance first reported a position in TMO in Q4 2022 and has held it in 10 quarters since. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Fiduciary Alliance held 1,725 shares of Thermo Fisher Scientific worth $1.16M as of Q3 2026.
  • Fiduciary Alliance bought 641 Thermo Fisher Scientific shares in Q3 2026, an estimated $381K.
  • Thermo Fisher Scientific made up 0.09% of Fiduciary Alliance's portfolio in Q3 2026, its #213 holding.
  • Fiduciary Alliance first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 10 quarters since.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.